Can Fin Homes Reports Strong Q3 Results Amidst Market Challenges and Valuation Adjustments
Can Fin Homes has recently adjusted its evaluation, reflecting strong long-term fundamentals, including an average Return on Equity of 16.93%. The company has reported positive results for 11 consecutive quarters, with net sales of Rs 986.11 crore and a profit after tax of Rs 212.12 crore in the latest quarter.
Can Fin Homes, a midcap player in the finance and housing sector, has recently undergone an adjustment in evaluation. This revision reflects the company's solid long-term fundamental strength, highlighted by an average Return on Equity (ROE) of 16.93%. The firm has consistently reported positive results over the last 11 consecutive quarters, with notable figures for the latest quarter, including net sales reaching Rs 986.11 crore and a profit after tax of Rs 212.12 crore.Despite a challenging year, where the stock generated a return of -14.54%, Can Fin Homes has seen its profits rise by 17.6%. The company's valuation remains attractive, supported by a Price to Book Value ratio of 2 and a PEG ratio of 0.6. Institutional holdings stand at 39.55%, indicating a robust backing from investors with significant analytical resources.
However, the stock is currently positioned within a bearish technical range, having experienced a decline of -10.51% since the beginning of January 2025. Various technical indicators suggest a cautious outlook, as the stock has underperformed relative to the BSE 500 over multiple time frames.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
